BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, February 28, 2026
Home » Authors » Tamra Sami

Articles by Tamra Sami

Australian government commits AU$22M to support translation of new technologies

Feb. 25, 2019
By Tamra Sami

Australia's Bionomics revives BNC-210 in PTSD following analysis of phase II failure

Feb. 20, 2019
By Tamra Sami
PERTH, Australia – Adelaide-based Bionomics Inc. is reviving lead compound BNC-210 after a deeper analysis of phase II data showed a positive effect in post-traumatic stress disorder (PTSD).
Read More

Australia's Bionomics revives BNC-210 in PTSD following analysis of phase II failure

Feb. 20, 2019
By Tamra Sami
PERTH, Australia – Adelaide-based Bionomics Inc. is reviving lead compound BNC-210 after a deeper analysis of phase II data showed a positive effect in post-traumatic stress disorder (PTSD).
Read More

Stakeholders oppose New Zealand's transparent approach in drug reclassification model

Feb. 20, 2019
By Tamra Sami
PERTH, Australia – Although industry stakeholders were generally supportive of New Zealand's Medicines and Medical Devices Safety Authority (Medsafe) proposed changes to the reclassification system for drugs in New Zealand, most vehemently opposed the idea of posting completed applications on the Medsafe website, citing competitive intellectual property concerns.
Read More

Stakeholders oppose New Zealand's transparent approach in drug reclassification model

Feb. 19, 2019
By Tamra Sami
PERTH, Australia – Although industry stakeholders were generally supportive of New Zealand's Medicines and Medical Devices Safety Authority (Medsafe) proposed changes to the reclassification system for drugs in New Zealand, most vehemently opposed the idea of posting completed applications on the Medsafe website, citing competitive intellectual property concerns.
Read More

Minomic spins out immuno-oncology company Glytherix

Feb. 15, 2019
By Tamra Sami

In drug pricing battle, Australia opts for pricing certainty over access to new therapies

Feb. 13, 2019
By Tamra Sami
PERTH, Australia – As pharma companies face global pricing pressures, value-based pricing mechanisms and health technology assessments more often than not determine which drugs get reimbursed and, ultimately, make it to the patient.
Read More

In drug pricing battle, Australia opts for pricing certainty over access to new therapies

Feb. 8, 2019
By Tamra Sami
PERTH, Australia – As pharma companies face global pricing pressures, value-based pricing mechanisms and health technology assessments more often than not determine which drugs get reimbursed and, ultimately, make it to the patient.
Read More

Global Kinetics' PKG yields real-world data to change management of PD patients

Feb. 7, 2019
By Tamra Sami

Australia's medical research institutes delivering on the promise of innovation

Feb. 6, 2019
By Tamra Sami
Previous 1 2 … 187 188 189 190 191 192 193 194 195 … 225 226 Next

Popular Stories

  • Today's news in brief

    BioWorld
  • Illustration of SCAN in Parkinson’s vs healthy subcortex

    SCAN is core circuit affected in Parkinson’s disease

    BioWorld
    Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
  • 3D rendering of skin cells and elastin with collagen layer

    First-in-class pan-inflammasome blocker for hidradenitis suppurativa

    BioWorld Science
    Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
  • Illustration of cancer cell in crosshairs being destroyed

    RX-10616 improves radiotherapy efficacy in HNSCC

    BioWorld Science
    Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
  • Brain and virus with chromosome

    CROI 2026: Neurodegeneration, the challenge of aging with HIV

    BioWorld
    Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing